Cargando…

Pharmacological induction of translational readthrough of nonsense mutations in the retinoblastoma (RB1) gene

The retinoblastoma protein (Rb) is encoded by the RB1 tumor suppressor gene. Inactivation of RB1 by inherited or somatic mutation occurs in retinoblastoma and various other types of tumors. A significant fraction (25.9%) of somatic RB1 mutations are nonsense substitutions leading to a premature term...

Descripción completa

Detalles Bibliográficos
Autores principales:	Palomar-Siles, Mireia, Yurevych, Viktor, Bykov, Vladimir J. N., Wiman, Klas G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10621805/ https://www.ncbi.nlm.nih.gov/pubmed/37917619 http://dx.doi.org/10.1371/journal.pone.0292468

Ejemplares similares

Translational readthrough of nonsense mutant TP53 by mRNA incorporation of 5-Fluorouridine
por: Palomar-Siles, Mireia, et al.
Publicado: (2022)

Novel compounds that synergize with aminoglycoside G418 or eRF3 degraders for translational readthrough of nonsense mutant TP53 and PTEN
por: Heldin, Angelos, et al.
Publicado: (2023)

Synergistic Rescue of Nonsense Mutant Tumor Suppressor p53 by Combination Treatment with Aminoglycosides and Mdm2 Inhibitors
por: Zhang, Meiqiongzi, et al.
Publicado: (2018)

Nonaminoglycoside compounds induce readthrough of nonsense mutations
por: Du, Liutao, et al.
Publicado: (2009)

Variable readthrough responsiveness of nonsense mutations in hemophilia A
por: Martorell, Lluis, et al.
Publicado: (2020)

Strategies against Nonsense: Oxadiazoles as Translational Readthrough-Inducing Drugs (TRIDs)
por: Campofelice, Ambra, et al.
Publicado: (2019)

Molecular Insights into Determinants of Translational Readthrough and Implications for Nonsense Suppression Approaches
por: Lombardi, Silvia, et al.
Publicado: (2020)

A small molecule that induces translational readthrough of CFTR nonsense mutations by eRF1 depletion
por: Sharma, Jyoti, et al.
Publicado: (2021)

Dbp5/DDX19 between Translational Readthrough and Nonsense Mediated Decay
por: Beißel, Christian, et al.
Publicado: (2020)

Functional Restoration of BRCA1 Nonsense Mutations by Aminoglycoside-Induced Readthrough
por: Abreu, Renata B. V., et al.
Publicado: (2022)

A system for coordinated analysis of translational readthrough and nonsense-mediated mRNA decay
por: Baker, Stacey L., et al.
Publicado: (2017)

Screening Readthrough Compounds to Suppress Nonsense Mutations: Possible Application to β-Thalassemia
por: Borgatti, Monica, et al.
Publicado: (2020)

Balancing Nonsense Mutation Readthrough and Toxicity of Designer Aminoglycosides for Treatment of Genetic Diseases
por: Guchhait, Sandip, et al.
Publicado: (2023)

Synergy between Readthrough and Nonsense Mediated Decay Inhibition in a Murine Model of Cystic Fibrosis Nonsense Mutations
por: McHugh, Daniel R., et al.
Publicado: (2020)

Stop Codon Context-Specific Induction of Translational Readthrough
por: Schilff, Mirco, et al.
Publicado: (2021)

Functional recovery of a novel knockin mouse model of dysferlinopathy by readthrough of nonsense mutation
por: Seo, Kyowon, et al.
Publicado: (2021)

2-Guanidino-quinazoline promotes the readthrough of nonsense mutations underlying human genetic diseases
por: Bidou, Laure, et al.
Publicado: (2022)

Evaluation of Novel Enhancer Compounds in Gentamicin-Mediated Readthrough of Nonsense Mutations in Rett Syndrome
por: Wong, Keit Men, et al.
Publicado: (2023)

Readthrough of nonsense mutations in Rett syndrome: evaluation of novel aminoglycosides and generation of a new mouse model
por: Brendel, Cornelia, et al.
Publicado: (2010)

Statistical Analysis of Readthrough Levels for Nonsense Mutations in Mammalian Cells Reveals a Major Determinant of Response to Gentamicin
por: Floquet, Célia, et al.
Publicado: (2012)

Erratum to: Readthrough of nonsense mutations in Rett syndrome: evaluation of novel aminoglycosides and generation of a new mouse model
por: Brendel, Cornelia, et al.
Publicado: (2013)

Nonsense suppression induced readthrough of a novel PAX6 mutation in patient‐derived cells of congenital aniridia
por: Liu, Xiaoliang, et al.
Publicado: (2020)

Expression of the eRF1 translation termination factor is controlled by an autoregulatory circuit involving readthrough and nonsense-mediated decay in plants
por: Nyikó, Tünde, et al.
Publicado: (2017)

Translational readthrough at F8 nonsense variants in the factor VIII B domain contributes to residual expression and lowers inhibitor association
por: Testa, Maria Francesca, et al.
Publicado: (2022)

Amlexanox: Readthrough Induction and Nonsense-Mediated mRNA Decay Inhibition in a Charcot–Marie–Tooth Model of hiPSCs-Derived Neuronal Cells Harboring a Nonsense Mutation in GDAP1 Gene
por: Benslimane, Nesrine, et al.
Publicado: (2023)

Cellular senescence limits translational readthrough
por: del Toro, Neylen, et al.
Publicado: (2021)

Mutational analysis of the RB1 gene in Moroccan patients with retinoblastoma
por: Abidi, Omar, et al.
Publicado: (2011)

Spectrum of mutations in the RB1 gene in Vietnamese patients with retinoblastoma
por: Kiet, Nguyen Cong, et al.
Publicado: (2019)

RB1 gene mutations and genetic spectrum in retinoblastoma cases
por: Akdeniz Odemis, Demet, et al.
Publicado: (2023)

Yeast applied readthrough inducing system (YARIS): an invivo assay for the comprehensive study of translational readthrough
por: Beznosková, Petra, et al.
Publicado: (2019)

Intergenic splicing-stimulated transcriptional readthrough is suppressed by nonsense-mediated mRNA decay in Arabidopsis
por: Kurihara, Yukio, et al.
Publicado: (2022)

NanoLuc reporters identify COL4A5 nonsense mutations susceptible to drug-induced stop codon readthrough
por: Omachi, Kohei, et al.
Publicado: (2022)

Small-molecule eRF3a degraders rescue CFTR nonsense mutations by promoting premature termination codon readthrough
por: Lee, Rhianna E., et al.
Publicado: (2022)

The RB1 gene mutation in a child with ectopic intracranial retinoblastoma.
por: Onadim, Z., et al.
Publicado: (1997)

RB1 mutations and second primary malignancies after hereditary retinoblastoma
por: Dommering, Charlotte J., et al.
Publicado: (2011)

Recoding of Nonsense Mutation as a Pharmacological Strategy
por: Temaj, Gazmend, et al.
Publicado: (2023)

Parental Origin of the RB1 Gene Mutations in Families with Low Penetrance Hereditary Retinoblastoma
por: Alekseeva, Ekaterina A., et al.
Publicado: (2021)

Clinical, Genomic, and Pharmacological Study of MYCN-Amplified RB1 Wild-Type Metastatic Retinoblastoma
por: Zugbi, Santiago, et al.
Publicado: (2020)

Spectrum of germ-line RB1 gene mutations in Malaysian patients with retinoblastoma
por: Mohd Khalid, Mohd Khairul Nizam, et al.
Publicado: (2015)

RB1 gene mutations in Argentine retinoblastoma patients. Implications for genetic counseling
por: Parma, Diana, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_2uv1a2b7fklqp3eq80hq1ckjqm